Shanghai Universal Biotech Co

Shanghai Universal Biotech Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Shanghai Universal Biotech Co (301166.SZ) as of Oct 20, 2026 is 190.08 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 46.99 % — a change of 304.50% (higher).

FCF Conversion

190.08 %

YoY

304.50%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Shanghai Universal Biotech Co is 2025 190.08 % . FCF Conversion Rate (FCF/EBITDA) of Shanghai Universal Biotech Co was 2024 46.99 % . It decreases by 304.50% higher compared to the previous year.

The Shanghai Universal Biotech Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
51.44 CNY
Jan 1, 2019
7.19 CNY
Jan 1, 2020
114.11 CNY
Jan 1, 2021
41.13 CNY
Jan 1, 2022
-192.12 CNY
Jan 1, 2023
-212.98 CNY
Jan 1, 2024
46.99 CNY
Jan 1, 2025
190.08 CNY
The Shanghai Universal Biotech Co FCF Conversion history
YEARFCF ConversionYoY
190.08 %+304.50%
46.99 %-122.06%
-212.98 %+10.86%
-192.12 %-567.15%
41.13 %-63.96%
114.11 %+1,487.55%
7.19 %-86.03%
51.44 %-140.69%
-126.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Universal Biotech Co Stock analysis

What does Shanghai Universal Biotech Co do? Shanghai Universal Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Universal Biotech Co stock

FCF Conversion Rate (FCF/EBITDA) of Shanghai Universal Biotech Co is 190.08 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Shanghai Universal Biotech Co changed from 46.99 % to 190.08 %, representing a 304.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Shanghai Universal Biotech Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Shanghai Universal Biotech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Shanghai Universal Biotech Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Shanghai Universal Biotech Co